Cargando…

Cytology–Based Specimen Triage for Epidermal Growth Factor Receptor Mutation Testing of Malignant Pleural Effusions in Non–Small Cell Lung Cancer

INTRODUCTION: Malignant pleural effusions are common in non–small cell lung cancer (NSCLC). Molecular testing is among the most critical steps in the management of patients with advanced NSCLC. However, the optimal approach for epidermal growth factor receptor (EGFR) mutation testing in such effusio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chiang, Chi-Lu, Shen, Chia-I, Huang, Hsu-Ching, Chang, Han-Jhih, Huang, Yu-Ting, Chiu, Chao-Hua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819005/ https://www.ncbi.nlm.nih.gov/pubmed/35141163 http://dx.doi.org/10.3389/fonc.2022.810124

Ejemplares similares

Malignant pleural effusion: Updates in diagnosis, management and current challenges
por: Addala, Dinesh Narayan, et al.
Publicado: (2022)

The Clinical and Cytological Investigation of Pleural Effusion
por: Robertson, R. F.
Publicado: (1954)

An uncommon diagnosis in pleural effusion cytology
por: Dubal, Sanjivani B., et al.
Publicado: (2021)

Current status of and progress in the treatment of malignant pleural effusion of lung cancer
por: Zhao, Yuhua, et al.
Publicado: (2023)

Evaluation of pleural fluid cytology for the diagnosis of malignant pleural effusion: a retrospective cohort study
por: Pairman, Lorna, et al.
Publicado: (2022)

Malignant pleural effusion supernatant is an alternative liquid biopsy specimen for comprehensive mutational profiling
por: Guo, Zhihua, et al.
Publicado: (2019)

Yield of closed pleural biopsy and cytology in exudative pleural effusion
por: Zuberi, Faisal Faiyaz, et al.
Publicado: (2016)

Malignant Pleural Effusions—A Window Into Local Anti-Tumor T Cell Immunity?
por: Principe, Nicola, et al.
Publicado: (2021)

A detection panel of novel methylated DNA markers for malignant pleural effusion
por: Liang, Chaonan, et al.
Publicado: (2022)

THE CYTOLOGY OF EFFUSIONS IN THE PLEURAL, PERICARDIAL AND PERITONEAL CAVITIES
Publicado: (1957)

Total Protein–Chloride Ratio in Pleural Fluid Independently Predicts Overall Survival in Malignant Pleural Effusion at the First Diagnosis
por: Qiao, Xin, et al.
Publicado: (2022)

Dasatinib-Induced Bilateral Pleural Effusions
por: Rasul, Taha F, et al.
Publicado: (2022)

Unexplained Pleural Effusion Leads to the Revelation of a Malignant Mesothelioma: A Case Report
por: Rhazari, Meriem, et al.
Publicado: (2022)

mRNA markers associated with malignant pleural effusion
por: Hsu, Shih-Chang, et al.
Publicado: (2023)

Treatment of malignant pleural effusion in non-small cell lung cancer with VEGF-directed therapy
por: Xiang, Zhangqiang, et al.
Publicado: (2022)

Cytological-energy analysis of pleural effusions with predominance of neutrophils
por: Matuchova, Inka, et al.
Publicado: (2020)

Challenging Diagnostic Process for a Malignant Peritoneal Mesothelioma Patient With Ascites and Pleural Effusion: A Case Report and Review of the Literature
por: Zeng, Xiaofeng, et al.
Publicado: (2022)

Pleural fluid cell-free DNA integrity index to identify cytologically negative malignant pleural effusions including mesotheliomas
por: Sriram, Krishna B, et al.
Publicado: (2012)

Malignant pleural mesothelioma with resolution of pleural effusion
por: Nishida, Sayaka, et al.
Publicado: (2023)

Intrapleural Administration With Rh-Endostatin and Chemical Irritants in the Control of Malignant Pleural Effusion: A Systematic Review and Meta-Analysis
por: Wang, Cheng-Qiong, et al.
Publicado: (2021)

Pleural effusion: Role of pleural fluid cytology, adenosine deaminase level, and pleural biopsy in diagnosis
por: Biswas, Biswajit, et al.
Publicado: (2016)

Development and Validation of a Scoring System for Early Diagnosis of Malignant Pleural Effusion Based on a Nomogram
por: Wu, Aihua, et al.
Publicado: (2021)

Double-Stranded DNA in Exosomes of Malignant Pleural Effusions as a Novel DNA Source for EGFR Mutation Detection in Lung Adenocarcinoma
por: Qu, Xueling, et al.
Publicado: (2019)

Usefulness of malignant pleural effusion for early cytological diagnosis of mesothelioma in situ: A case report
por: Yabuuchi, Yuki, et al.
Publicado: (2022)

Management of Malignant Pleural Effusions
por: Villanueva, Andrew G.
Publicado: (2012)

Management of Malignant Pleural Effusions
por: Charpidou, Adrianni, et al.
Publicado: (2006)

High-throughput autoantibody analysis in malignant pleural effusion and tuberculosis pleural effusion
por: Yi, Fengshuang, et al.
Publicado: (2019)

Novel biomarker analysis of pleural effusion enhances differentiation of tuberculous from malignant pleural effusion
por: Chen, Kuan-Yuan, et al.
Publicado: (2016)

Management of malignant pleural effusion with different pleural catheters
por: Karapolat, Sami, et al.
Publicado: (2018)

Malignant pleural effusions: Differentiating pelvic malignancies
por: Sharma, Mukesh, et al.
Publicado: (2015)

Fluorescence in situ hybridization as adjunct to cytology improves the diagnosis and directs estimation of prognosis of malignant pleural effusions
por: Han, Jingquan, et al.
Publicado: (2012)

Malignant Pleural Effusion from Metastatic Prostate Cancer: A Case Report with Unusual Cytologic Findings
por: Jeon, Jinyoung, et al.
Publicado: (2018)

Modified Liquid-Based Cytology Technique for Immunocytochemistry in Effusion Specimen
por: Patarapadungkit, Natcha, et al.
Publicado: (2019)

Survival Benefits for Pulmonary Adenocarcinoma With Malignant Pleural Effusion After Thoracoscopic Surgical Treatment: A Real-World Study
por: Li, Xin, et al.
Publicado: (2022)

Lung adenocarcinoma patients with malignant pleural effusions in hot adaptive immunity status have a longer overall survival
por: Wu, Cheng-Guang, et al.
Publicado: (2022)

Failure pattern and radiotherapy exploration in malignant pleural effusion non-small cell lung cancer treated with targeted therapy
por: Li, Qingsong, et al.
Publicado: (2023)

Differentiating malignant and benign pleural effusion in patients with lung cancer: an (18)F-FDG PET/CT retrospectively study
por: Zhang, Weishan, et al.
Publicado: (2023)

Use of Platelet Parameters in the Differential Diagnosis of Lung Adenocarcinoma-Associated Malignant Pleural Effusion and Tuberculous Pleural Effusion
por: Ai, Ling, et al.
Publicado: (2022)

An Update in the Management of Malignant Pleural Effusion
por: Muduly, DK, et al.
Publicado: (2011)

Ferritin Assay in Malignant Pleural Effusion
por: Chung, Won-Tae, et al.
Publicado: (1987)

Cannot write session to /tmp/vufind_sessions/sess_qp39ud5prolp0gge2m1glr86eb